# Short Stature Related Distress

> **NCT01246219** · PHASE4 · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Idiopathic Short Stature
- Self Image

## Interventions

- **DRUG:** GH treatment (Genotropin)
- **DRUG:** 1 year treatment with placebo followed by optional 3 years of GH treatment

## Key facts

- **NCT ID:** NCT01246219
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246219, "Short Stature Related Distress". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01246219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*